Excellent outcomes with adjuvant toremif
โ
Jaime D. Lewis; Anees B. Chagpar; Elizabeth A. Shaughnessy; Jacob Nurko; Kelly M
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 184 KB
๐ 1 views
## Abstract ## BACKGROUND: Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early stage breast cancer wo